New York 2025-2026 Regular Session

New York Assembly Bill A01462

Introduced
1/9/25  

Caption

Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients.

Companion Bills

NY S00586

Same As Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients.

Previously Filed As

NY S09858

Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients.

NY A10679

Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients.

NY A08414

Establishes a central business district toll exemption for officers and employees of the city of New York, first responders, physicians, nurses, and people entering the city for medical treatment.

NY S04362

Shortens time frames during which an insurer has to determine whether a pre-authorization request is medically necessary from three business days to three days.

NY A02460

Requires the state to reimburse non-public and private schools for the cost of testing where COVID-19 testing is being mandated by the state.

NY A00750

Establishes a training program for first responders for responding to victims of suspected drug overdose and the administration of opioid antagonists.

NY S03591

Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.

NY A06564

Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.

NY S01342

Limits availability and coverage for non-invasive prenatal testing for Medicaid patients based on age if such limits are recommended by the United States food and drug administration, the centers for Medicare and Medicaid services, or the United States department of health and human services.

NY A00997

Limits availability and coverage for non-invasive prenatal testing for Medicaid patients based on age if such limits are recommended by the United States food and drug administration, the centers for Medicare and Medicaid services, or the United States department of health and human services.

Similar Bills

No similar bills found.